In this issue of Hematology/Oncology Clinics, guest editor David A. Reardon? brings his considerable expertise to the topic of Central Nervous System Malignancies. Top experts in the field cover key topics such as CNS Metastases, Leptomeningeal Disease, Neurofibromatoses, Imaging Advances for CNS Tumors, and more.
Contains 16 relevant, practice-oriented topics including CNS Tumor Classification: An Update on the Integration of Tumor Genetics; Etiology and Epidemiology of CNS Tumors; The Evolving Role of Neurosurgical Intervention for CNS Tumor ; Update on Radiation Therapy for CNS Tumors; and more.
Provides in-depth clinical reviews on CNS Malignancies, offering actionable insights for clinical practice.
Presents the latest information on this timely, focused topic under the leadership of experienced editors in the field. Authors synthesize and distill the latest research and practice guidelines to create clinically significant, topic-based reviews.
1. Cover image - p. i 2. Title page - p. i 3. Table of Contents - p. i 4. Copyright - p. ii 5. Contributors - p. iii 6. Forthcoming Issues - p. xiv 7. Preface - p. xv 8. Central Nervous System Tumor Classification: An Update on the Integration of Tumor Genetics - p. 1 9. The Epidemiology of Central Nervous System Tumors - p. 23 10. Imaging Advances for Central Nervous System Tumors - p. 43 11. The Evolving Role of Neurosurgical Intervention for Central Nervous System Tumors - p. 63 12. Update on Radiation Therapy for Central Nervous System Tumors - p. 77 13. Isocitrate Dehydrogenase Mutant Grade II and III Glial Neoplasms - p. 95 14. Isocitrate Dehydrogenase Wild-type Glial Tumors, Including Glioblastoma - p. 113 15. Biology and Treatment of Meningiomas: A Reappraisal - p. 133 16. Primary Central Nervous System Lymphomas - p. 147 17. Central Nervous System Metastases - p. 161 18. Leptomeningeal Disease - p. 189 19. Central Nervous System Complications Among Oncology Patients - p. 217 20. Is There a Role for Immunotherapy in Central Nervous System Cancers? - p. 237 21. Neurofibromatoses - p. 253 22. Neurocognition and Health-Related Quality of Life Among Patients with Brain Tumors - p. 269 23. Disparities and Inequities Among Patients with Central Nervous System Tumor - p. e1
In this issue of Hematology/Oncology Clinics, guest editor David A. Reardon? brings his considerable expertise to the topic of Central Nervous System Malignancies. Top experts in the field cover key topics such as CNS Metastases, Leptomeningeal Disease, Neurofibromatoses, Imaging Advances for CNS Tumors, and more.
Contains 16 relevant, practice-oriented topics including CNS Tumor Classification: An Update on the Integration of Tumor Genetics; Etiology and Epidemiology of CNS Tumors; The Evolving Role of Neurosurgical Intervention for CNS Tumor ; Update on Radiation Therapy for CNS Tumors; and more.
Provides in-depth clinical reviews on CNS Malignancies, offering actionable insights for clinical practice.
Presents the latest information on this timely, focused topic under the leadership of experienced editors in the field. Authors synthesize and distill the latest research and practice guidelines to create clinically significant, topic-based reviews.
1. Cover image - p. i 2. Title page - p. i 3. Table of Contents - p. i 4. Copyright - p. ii 5. Contributors - p. iii 6. Forthcoming Issues - p. xiv 7. Preface - p. xv 8. Central Nervous System Tumor Classification: An Update on the Integration of Tumor Genetics - p. 1 9. The Epidemiology of Central Nervous System Tumors - p. 23 10. Imaging Advances for Central Nervous System Tumors - p. 43 11. The Evolving Role of Neurosurgical Intervention for Central Nervous System Tumors - p. 63 12. Update on Radiation Therapy for Central Nervous System Tumors - p. 77 13. Isocitrate Dehydrogenase Mutant Grade II and III Glial Neoplasms - p. 95 14. Isocitrate Dehydrogenase Wild-type Glial Tumors, Including Glioblastoma - p. 113 15. Biology and Treatment of Meningiomas: A Reappraisal - p. 133 16. Primary Central Nervous System Lymphomas - p. 147 17. Central Nervous System Metastases - p. 161 18. Leptomeningeal Disease - p. 189 19. Central Nervous System Complications Among Oncology Patients - p. 217 20. Is There a Role for Immunotherapy in Central Nervous System Cancers? - p. 237 21. Neurofibromatoses - p. 253 22. Neurocognition and Health-Related Quality of Life Among Patients with Brain Tumors - p. 269 23. Disparities and Inequities Among Patients with Central Nervous System Tumor - p. e1
